EXCLUSIVE-AstraZeneca exploring options for COVID-19 vaccine business, exec says

AstraZeneca is exploring its options for the future of its COVID-19 vaccine business and expects greater clarity on the matter by the end of 2021, a senior executive told Reuters on Thursday.

"We are exploring different options," Ruud Dobber, executive vice president and president of BioPharmaceuticals Business Unit, told Reuters about the vaccines business.

"Before year-end, we will have more clarity... if you ask me, is the vaccine businesses a sustainable business for AstraZeneca for the next five or 10 years, that big strategic question is under discussion."

Also Read: Thailand considering limits on AstraZeneca vaccine exports